Auflistung Dokumente Charité nach Autor*in "Kaiser, Florian"

Refubium - Repositorium der Freien Universität Berlin

Mikronavigation

Auflistung Dokumente Charité nach Autor*in "Kaiser, Florian"

Dokument
Erscheinungsdatum
Wissenschaftlicher ArtikelFOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trialHeinemann, Volker; Weikersthal, Ludwig Fischer von; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmüller, Christoph; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Held, Swantje; Miller-Phillips, Lisa; Modest, Dominik Paul; Jung, Andreas; Kirchner, Thomas; Stintzing, Sebastian
2020
Wissenschaftlicher ArtikelMutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3)Stahler, Arndt; Heinemann, Volker; Holch, Julian Walter; Einem, Jobst Christian von; Westphalen, Christoph Benedikt; Heinrich, Kathrin; Schlieker, Laura; Jelas, Ivan; Alig, Annabel Helga Sophie; Fischer, Laura Elisabeth; Weiss, Lena; Modest, Dominik Paul; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Moehler, Markus; Kaiser, Florian; Kirchner, Thomas; Jung, Andreas; Stintzing, Sebastian
2021
Wissenschaftlicher ArtikelResponse and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI TrialKurreck, Annika; Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Graeven, Ullrich; Heinrich, Kathrin; Held, Swantje; Stahler, Arndt; Alig, Annabel Helga Sophie; Jelas, Ivan; Einem, Jobst C. von; Stintzing, Sebastian; Giessen-Jung, Clemens; Modest, Dominik P.
2022
Wissenschaftlicher ArtikelStudy protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancerSommerhäuser, Greta; Kurreck, Annika; Stintzing, Sebastian; Heinemann, Volker; Weikersthal, Ludwig Fischer von; Dechow, Tobias; Kaiser, Florian; Karthaus, Meinolf; Schwaner, Ingo; Fuchs, Martin; König, Alexander; Roderburg, Christoph; Hoyer, Inna; Quante, Michael; Kiani, Alexander; Fruehauf, Stefan; Müller, Lothar; Reinacher-Schick, Anke; Ettrich, Thomas J.; Stahler, Arndt; Modest, Dominik P.
2022